Paper9506239
Combination diuretic therapy in severe congestive heart failure.
Dormans TP and 3 others. Drugs, 1998. Cited by 36 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Combination diuretic therapy in severe congestive heart failure. Papers, record 9506239. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9506239
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diuretics | Major topic |
| Heart Failure | Major topic |
| Kidney | Major topic |
| Drug Resistance | |
| Drug Synergism | |
| Drug Therapy, Combination | |
| Humans |
Source PubMed
References58
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 2,811,065 | Mechanism of impaired natriuretic response to furosemide during prolonged therapy. | Kidney Int | 1989 | https://conductscience.org/library/papers/2811065 | PubMed |
| 2 | 4,056,058 | Role of renal sympathetic nerves in mediating hypoperfusion of renal cortical microcirculation in experimental congestive heart failure and acute extracellular fluid volume depletion. | J Clin Invest | 1985 | https://conductscience.org/library/papers/4056058 | PubMed |
| 3 | 8,422,000 | Spironolactone in congestive heart failure refractory to high-dose loop diuretic and low-dose angiotensin-converting enzyme inhibitor. | Am J Cardiol | 1993 | https://conductscience.org/library/papers/8422000 | PubMed |
| 4 | 2,014,951 | The physiologic basis of diuretic synergism: its role in treating diuretic resistance. | Ann Intern Med | 1991 | https://conductscience.org/library/papers/2014951 | PubMed |
| 5 | 8,800,113 | Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion. | J Am Coll Cardiol | 1996 | https://conductscience.org/library/papers/8800113 | PubMed |
| 6 | 9,152,644 | The treatment of heart failure. Task Force of the Working Group on Heart Failure of the European Society of Cardiology. | Eur Heart J | 1997 | https://conductscience.org/library/papers/9152644 | PubMed |
| 7 | 1,858,894 | Adaptation of distal convoluted tubule of rats. II. Effects of chronic thiazide infusion. | Am J Physiol | 1991 | https://conductscience.org/library/papers/1858894 | PubMed |
| 8 | 8,944,582 | Increase in hospital admission rates for heart failure in The Netherlands, 1980-1993. | Heart | 1996 | https://conductscience.org/library/papers/8944582 | PubMed |
| 9 | 8,151,264 | Continuous infusion of furosemide in the treatment of patients with congestive heart failure and diuretic resistance. | J Intern Med | 1994 | https://conductscience.org/library/papers/8151264 | PubMed |
| 10 | 9,284,857 | Role of duration of diuretic effect in preventing sodium retention. | Clin Pharmacol Ther | 1997 | https://conductscience.org/library/papers/9284857 | PubMed |
| 11 | 3,631,283 | Thiazide-sensitive sodium chloride cotransport in early distal tubule. | Am J Physiol | 1987 | https://conductscience.org/library/papers/3631283 | PubMed |
| 12 | 2,188,836 | Sympathetic activation in congestive heart failure. | Eur Heart J | 1990 | https://conductscience.org/library/papers/2188836 | PubMed |
| 13 | 1,967,337 | Metolazone in treatment of severe refractory congestive cardiac failure. | Lancet | 1990 | https://conductscience.org/library/papers/1967337 | PubMed |
| 14 | 8,689,815 | Pharmacodynamic modeling of furosemide tolerance after multiple intravenous administration. | Clin Pharmacol Ther | 1996 | https://conductscience.org/library/papers/8689815 | PubMed |
| 15 | 8,583,780 | Diuretic effectiveness of hydrochlorothiazide and furosemide alone and in combination in chronic renal failure. | J Cardiovasc Pharmacol | 1995 | https://conductscience.org/library/papers/8583780 | PubMed |
| 16 | 9,125,675 | Sequential nephron blockade breaks resistance to diuretics in edematous states. | J Cardiovasc Pharmacol | 1997 | https://conductscience.org/library/papers/9125675 | PubMed |
| 17 | 1,352,022 | Pathophysiology of chronic heart failure. | Lancet | 1992 | https://conductscience.org/library/papers/1352022 | PubMed |
| 18 | 1,970,014 | Thiazides with loop diuretics for severe congestive heart failure. | Lancet | 1990 | https://conductscience.org/library/papers/1970014 | PubMed |
| 19 | 6,503,136 | Bumetanide and furosemide in heart failure. | Kidney Int | 1984 | https://conductscience.org/library/papers/6503136 | PubMed |
| 20 | 4,950,425 | Combination diuretic drug therapy. | Cardiovasc Clin | 1971 | https://conductscience.org/library/papers/4950425 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 36 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38,541,899 | The Changing Role of Loop Diuretics in Heart Failure Management across the Last Century. | J Clin Med | 2024 | https://conductscience.org/library/papers/38541899 | PubMed |
| 34,852,633 | Nalfurafine, a G-Protein-Biased KOR (Kappa Opioid Receptor) Agonist, Enhances the Diuretic Response and Limits Electrolyte Losses to Standard-of-Care Diuretics. | Hypertension | 2022 | https://conductscience.org/library/papers/34852633 | PubMed |
| 33,392,884 | Pharmacologic and interventional paradigms of diuretic resistance in congestive heart failure: a narrative review. | Int Urol Nephrol | 2021 | https://conductscience.org/library/papers/33392884 | PubMed |
| 26,521,190 | Hypertonic Saline in Conjunction with High-Dose Furosemide Improves Dose-Response Curves in Worsening Refractory Congestive Heart Failure. | Adv Ther | 2015 | https://conductscience.org/library/papers/26521190 | PubMed |
| 24,357,134 | Managing therapeutic competition in patients with heart failure, lower urinary tract symptoms and incontinence. | Drugs Aging | 2014 | https://conductscience.org/library/papers/24357134 | PubMed |
| 24,223,323 | Acute Heart Failure Treatment. | Curr Emerg Hosp Med Rep | 2013 | https://conductscience.org/library/papers/24223323 | PubMed |
| 23,319,101 | Causes and treatment of oedema in patients with heart failure. | Nat Rev Cardiol | 2013 | https://conductscience.org/library/papers/23319101 | PubMed |
| 17,245,481 | Canadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007: Prevention, management during intercurrent illness or acute decompensation, and use of biomarkers. | Can J Cardiol | 2007 | https://conductscience.org/library/papers/17245481 | PubMed |
| 15,809,817 | The cardiorenal syndrome: lessons from the ADHERE database and treatment options. | Heart Fail Rev | 2004 | https://conductscience.org/library/papers/15809817 | PubMed |
| 12,038,877 | Severe heart failure in the elderly: potential benefits of high-dose and continuous infusion diuretics. | Drugs Aging | 2002 | https://conductscience.org/library/papers/12038877 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9506239
GET https://conductscience.org/api/papers/v1/9506239/references?page=2